DaVita (DVA) Stock May Be Undervalued On Its Earnings Power

DaVita has delivered a strong 87.2% share price gain over the past three years, which naturally raises a question for anyone looking at the stock today. Is the current valuation still grounded in the earnings power of the dialysis provider, or has the share price moved ahead of what the business is generating? A roughly 87.2% return over three years puts real weight on whether DaVita's earnings profile can support the price investors are paying today. The business leans on recurring...